Health Catalyst, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Health Catalyst, Inc. (HCAT), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are HCAT insiders buying or selling?
In the last 12 months, Health Catalyst, Inc. insiders reported 1 open-market purchase ($105.4K) and 2 sales ($200.7K) — net selling of $95.2K. Since March 2020, Trabud has recorded 225 Form 4 filings for HCAT: 7 buys ($6.0M) and 218 sells ($98.5M).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $105.4K by Simeon Kohl (Chief Executive Officer) on Sep 16, 2026. SEC ↗
- The most recent open-market purchase was reported on Sep 16, 2026 (32 days ago).
Key Statistics (March 2020 – Sep 16, 2026)
Total Form 4 filings
225
SEC EDGAR
Insider filers
18
Insider buys (7)
$6.0M
Insider sells (218)
$98.5M
Insider sentiment
Net sellingNet insider flow of $92.4M in net selling since March 2020, and $95.2K in net selling over the last 12 months. 1 insider buy in the last 90 days.
Recent HCAT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Simeon Kohl | Chief Executive Officer | Purchase | 59.0K | $1.79 | $105.4K | SEC ↗ |
| Dec 9, 2025 | Benjamin Landry | General Counsel | Sale | 27.4K | $2.64 | $72.3K | SEC ↗ |
| Dec 9, 2025 | Julie Larson-Green | Director | Sale | 48.0K | $2.67 | $128.3K | SEC ↗ |
| Sep 9, 2025 | Benjamin Landry | General Counsel | Sale | 6.2K | $3.35 | $20.7K | SEC ↗ |
| Jun 9, 2025 | Benjamin Landry | General Counsel | Sale | 6.1K | $3.94 | $23.9K | SEC ↗ |
| May 7, 2025 | Daniel Lesueur | Chief Operating Officer | Sale | 5.2K | $4.10 | $21.3K | SEC ↗ |
| Apr 7, 2025 | Daniel Lesueur | Chief Operating Officer | Sale | 5.2K | $4.15 | $21.6K | SEC ↗ |
| Mar 10, 2025 | Benjamin Landry | General Counsel | Sale | 13.8K | $4.55 | $62.9K | SEC ↗ |
| Mar 10, 2025 | Daniel Lesueur | Chief Operating Officer | Sale | 16.9K | $4.52 | $76.3K | SEC ↗ |
| Feb 21, 2025 | Linda Llewelyn | Chief People Officer | Sale | 6.4K | $5.43 | $35.0K | SEC ↗ |
| Feb 6, 2025 | Daniel Lesueur | Chief Operating Officer | Sale | 5.2K | $5.76 | $30.0K | SEC ↗ |
| Jan 18, 2025 | Linda Llewelyn | Chief People Officer | Sale | 6.4K | $5.80 | $37.3K | SEC ↗ |
| Jan 10, 2025 | Daniel Lesueur | Chief Operating Officer | Sale | 5.2K | $7.51 | $39.1K | SEC ↗ |
| Jan 10, 2025 | Benjamin Landry | General Counsel | Sale | 2.5K | $7.52 | $18.8K | SEC ↗ |
| Jan 2, 2025 | Duncan Gallagher | Director | Sale | 4.5K | $6.93 | $31.2K | SEC ↗ |
| Dec 27, 2024 | Duncan Gallagher | Director | Sale | 4.5K | $6.98 | $31.4K | SEC ↗ |
| Dec 18, 2024 | Linda Llewelyn | Chief People Officer | Sale | 6.4K | $7.88 | $50.8K | SEC ↗ |
| Dec 10, 2024 | Jason Alger | Chief Financial Officer | Sale | 19.6K | $8.32 | $163.0K | SEC ↗ |
| Dec 10, 2024 | Benjamin Landry | General Counsel | Sale | 19.3K | $8.32 | $160.3K | SEC ↗ |
| Dec 6, 2024 | Daniel Lesueur | Chief Operating Officer | Sale | 22.8K | $7.70 | $175.2K | SEC ↗ |
| Dec 3, 2024 | Kevin Lee Freeman | Chief Commercial Officer | Sale | 7.5K | $8.94 | $67.1K | SEC ↗ |
| Nov 18, 2024 | Linda Llewelyn | Chief People Officer | Sale | 1.4K | $8.50 | $11.6K | SEC ↗ |
| Nov 7, 2024 | Daniel Lesueur | Chief Operating Officer | Sale | 5.2K | $7.70 | $40.1K | SEC ↗ |
| Oct 17, 2024 | Linda Llewelyn | Chief People Officer | Sale | 1.3K | $8.16 | $10.8K | SEC ↗ |
| Oct 8, 2024 | Daniel Lesueur | Chief Operating Officer | Sale | 5.2K | $7.68 | $40.0K | SEC ↗ |
Showing the 25 most recent of 225 Form 4 filings for Health Catalyst, Inc..
Most active HCAT insiders
- Linda Llewelyn58 filings
- Paul Horstmeier29 filings
- Daniel H. Orenstein25 filings
- Daniel D. Burton18 filings
- Jason Alger15 filings
Ask anything about HCAT insider activity
Use Trabud's AI agent to query Health Catalyst, Inc.'s Form 4 history in plain English — "Show me HCAT CEO purchases this year" or compare it against any other ticker.
Open the AI agentHCAT insider trading FAQ
Are Health Catalyst, Inc. insiders buying or selling?
In the last 12 months, Health Catalyst, Inc. insiders reported 1 open-market purchase ($105.4K) and 2 sales ($200.7K) — net selling of $95.2K. Since March 2020, Trabud has recorded 225 Form 4 filings for HCAT: 7 buys ($6.0M) and 218 sells ($98.5M). Over the full record that is net selling of $92.4M.
How many insiders trade HCAT stock?
18 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Health Catalyst, Inc.. The most recent filing was accepted on Sep 16, 2026.
Where does Trabud get HCAT insider trading data?
All HCAT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.